Business Description
Pharmala Biotech Holdings Inc
NAICS : 541710
SIC : 3741
ISIN : CA71719L1067
Total Employee Number:
5Description
Pharmala Biotech Holdings Inc is a Canadian Biotechnology company focused on the development, manufacture and sales of MDMA and MDXX class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The company produces its MDMA active pharmaceutical ingredient under the LaNeo brand through Good Manufacturing Practice (GMP) processes, aiming to address shortages for clinical trials investigating treatments for various disorders. It generates revenue from the sale of tablets, raw MDMA and MDXX compounds/formulations, and royalties from licensing of its IP.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.64 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 9.86 | |||||
Beneish M-Score | -1.09 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 81.7 | |||||
3-Year EBITDA Growth Rate | -18.6 | |||||
3-Year EPS without NRI Growth Rate | -23.9 | |||||
3-Year FCF Growth Rate | 18.1 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 76.71 | |||||
9-Day RSI | 75.64 | |||||
14-Day RSI | 73.22 | |||||
3-1 Month Momentum % | -8.57 | |||||
6-1 Month Momentum % | 52.38 | |||||
12-1 Month Momentum % | 28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.17 | |||||
Quick Ratio | 0.64 | |||||
Cash Ratio | 0.21 | |||||
Days Inventory | 577.94 | |||||
Days Sales Outstanding | 48.46 | |||||
Days Payable | 504.11 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 79.08 | |||||
Operating Margin % | -125.41 | |||||
Net Margin % | -126.99 | |||||
EBITDA Margin % | -116.02 | |||||
FCF Margin % | -81.14 | |||||
OCF Margin % | -76.4 | |||||
ROE % | -68.81 | |||||
ROA % | -48.32 | |||||
ROIC % | -71.13 | |||||
3-Year ROIIC % | -131.06 | |||||
ROC (Joel Greenblatt) % | -63560 | |||||
ROCE % | -68.07 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 19.62 | |||||
PB Ratio | 14.17 | |||||
EV-to-EBIT | -17.38 | |||||
EV-to-EBITDA | -18.78 | |||||
EV-to-Revenue | 21.79 | |||||
EV-to-FCF | -26.86 | |||||
Price-to-GF-Value | 1.02 | |||||
Earnings Yield (Greenblatt) % | -5.75 | |||||
FCF Yield % | -3.69 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharmala Biotech Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 1.267 | ||
| EPS (TTM) (C$) | -0.01 | ||
| Beta | 1.0155 | ||
| 3-Year Sharpe Ratio | 0.24 | ||
| 3-Year Sortino Ratio | 0.51 | ||
| Volatility % | 67.27 | ||
| 14-Day RSI | 73.22 | ||
| 14-Day ATR (C$) | 0.020972 | ||
| 20-Day SMA (C$) | 0.18475 | ||
| 12-1 Month Momentum % | 28 | ||
| 52-Week Range (C$) | 0.085 - 0.29 | ||
| Shares Outstanding (Mil) | 109.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharmala Biotech Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharmala Biotech Holdings Inc Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharmala Biotech Holdings Inc Frequently Asked Questions
What is Pharmala Biotech Holdings Inc(XCNQ:MDMA)'s stock price today?
The current price of XCNQ:MDMA is C$0.25. The 52 week high of XCNQ:MDMA is C$0.29 and 52 week low is C$0.09.
When is next earnings date of Pharmala Biotech Holdings Inc(XCNQ:MDMA)?
The next earnings date of Pharmala Biotech Holdings Inc(XCNQ:MDMA) is .
Does Pharmala Biotech Holdings Inc(XCNQ:MDMA) pay dividends? If so, how much?
Pharmala Biotech Holdings Inc(XCNQ:MDMA) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| The Power Play by The Market Herald Releases New Interviews with Pharmala Biotech Holdings, Nextech AR Solutions and Enertopia Discussing Their Latest News | 2023-01-27 |
Articles on Pharmala Biotech Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers